Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Acquisition

9 Aug 2017 07:00

RNS Number : 4471N
Scapa Group PLC
09 August 2017
 

 

 

 

 

9 August 2017

 

 

 

Scapa Group plc 

Acquisition of Markel Industries

 

 

 

Scapa Group plc ("Scapa") (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the healthcare and industrial markets, is pleased to announce that it has acquired the entire share capital of Markel Industries, Controlled Environment Equipment Corp and CMark Films, LLC (together the "Company" or "Markel") for a total purchase price of USD$10 million.

Markel is a leading North American manufacturer of adhesive floor mats and tacky rollers for use in medical clean rooms, electronic and industrial assembly areas, construction site and sports venues.

As at 31 December 2016, the unaudited gross assets acquired were USD$1.2 million. Underlying adjusted EBITDA for the year ended 31 December 2016 was USD$1.7 million. The acquisition is expected to be earnings enhancing in the first full year and will be funded from existing cash reserves and bank facilities.

The Board believes the acquisition of Markel will give the following benefits:

· Markel's largely North American customer base has a similar profile to Scapa's, offering cross-selling opportunities

· Markel's high quality core clean room contamination prevention products will enhance Scapa's current products offerings in Europe

· Meaningful overlap in supply chain and manufacturing technology as well as proximity of Markel's manufacturing sites to Scapa offer an opportunity for efficiencies

Commenting on the acquisition, Heejae Chae, the Group Chief Executive Officer of Scapa, said:

"The acquisition of Markel is a part of our Industrial strategy to further drive the Return on Capital Employed through concentration on our core customers and markets as well as optimisation of our manufacturing assets."

 

 

For further information:

 

Scapa Group plc

Heejae Chae - Chief Executive

Graham Hardcastle - Finance Director

 

 

 0161 301 7430

Numis Securities Limited

(Nominated Adviser and Joint Broker)

Richard Thomas/Mark Lander

 020 7260 1000

 

Berenberg

(Joint Broker)

Chris Bowman

 

Weber Shandwick Financial PR

Nick Oborne

 

 020 3207 7800

 

 

 

020 7067 0000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBUGDIISGBGRI
Date   Source Headline
2nd Jul 20184:33 pmRNSTotal Voting Rights
28th Jun 20184:12 pmRNSDirector/PDMR Shareholding
5th Jun 20184:00 pmRNSDirector/PDMR Shareholding
31st May 201810:31 amRNSTotal Voting Rights
30th May 201810:20 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
30th Apr 201810:30 amRNSTotal Voting Rights
12th Apr 20187:00 amRNSTrading Statement
11th Apr 20183:29 pmRNSIncident at Dunstable Site
29th Mar 201811:48 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSAcquisition
28th Feb 20181:38 pmRNSTotal Voting Rights
7th Feb 20189:17 amRNSBlock listing Interim Review
31st Jan 20189:08 amRNSTotal Voting Rights
25th Jan 20182:14 pmRNSBlock listing Interim Review
8th Jan 201810:10 amRNSDirectorate Change
7th Dec 20173:52 pmRNSDirector/PDMR Shareholding
7th Dec 20173:49 pmRNSAdditional Listing
29th Nov 201711:15 amRNSDirector/PDMR Shareholding
28th Nov 20172:56 pmRNSDirector/PDMR Shareholding
28th Nov 20172:44 pmRNSDirector/PDMR Shareholding
23rd Nov 20179:36 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
17th Nov 201710:22 amRNSAdditional Listing
11th Oct 20177:00 amRNSTrading Statement
4th Oct 20177:00 amRNSCapital Markets Day
26th Sep 201711:38 amRNSAdditional Listing
21st Sep 20174:21 pmRNSHolding(s) in Company
8th Sep 201711:31 amRNSDirector/PDMR Shareholding
4th Sep 20173:18 pmRNSDirector/PDMR Shareholding
4th Sep 201710:13 amRNSAdditional Listing
25th Aug 20177:00 amRNSDirector/PDMR Shareholding
17th Aug 20174:14 pmRNSDirector/PDMR Shareholding
11th Aug 20174:12 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSAcquisition
7th Aug 20171:56 pmRNSBlock listing Interim Review
25th Jul 201710:09 amRNSBlock listing Interim Review
19th Jul 20179:29 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSAGM Statement
1st Jun 20171:59 pmRNSHolding(s) in Company
30th May 20172:09 pmRNSAdditional Listing
23rd May 20177:00 amRNSFinal Results
18th May 20173:47 pmRNSHolding(s) in Company
17th May 20173:36 pmRNSHolding(s) in Company
3rd May 201710:31 amRNSAdditional Listing
21st Apr 20179:41 amRNSHolding(s) in Company
19th Apr 20173:33 pmRNSAdditional Listing
13th Apr 20177:00 amRNSTrading Statement
27th Mar 20172:05 pmRNSDirector/PDMR Shareholding
23rd Mar 201711:46 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.